Haefeli WE - Search Results

1

High prevalence of unknown co-medication in hospitalised patients.

Rieger K, Scholer A, Arnet I, Peters FT, Maurer HH, Walter-Sack I, Haefeli WE, Martin-Facklam M. Rieger K, et al. Among authors: haefeli we. Eur J Clin Pharmacol. 2004 Jul;60(5):363-8. doi: 10.1007/s00228-004-0784-6. Epub 2004 Jun 10. Eur J Clin Pharmacol. 2004. PMID: 15197522

2

Recurrent ventricular fibrillation in mianserin intoxication.

Haefeli WE, Schoenenberger RA, Scholer A. Haefeli WE, et al. BMJ. 1991 Feb 16;302(6773):415-6. doi: 10.1136/bmj.302.6773.415-d. BMJ. 1991. PMID: 2004160 Free PMC article. No abstract available.

3

[Conviction as a basis for compliance and strategies for improving compliance].

Arnet I, Schoenenberger RA, Spiegel R, Haefeli WE. Arnet I, et al. Among authors: haefeli we. Schweiz Med Wochenschr. 1999 Oct 16;129(41):1477-86. Schweiz Med Wochenschr. 1999. PMID: 10555251 German.

4

Overconsumption detected by electronic drug monitoring requires subtle interpretation.

Arnet I, Haefeli WE. Arnet I, et al. Among authors: haefeli we. Clin Pharmacol Ther. 2000 Jan;67(1):44-7. doi: 10.1067/mcp.2000.103821. Clin Pharmacol Ther. 2000. PMID: 10668852 Clinical Trial.

5

[Drug interactions with the cytochrome P-450 system].

Martin-Facklam M, Drewe J, Haefeli WE. Martin-Facklam M, et al. Among authors: haefeli we. Dtsch Med Wochenschr. 2000 Jan 21;125(3):63-7. doi: 10.1055/s-2007-1023908. Dtsch Med Wochenschr. 2000. PMID: 10682001 Review. German. No abstract available.

6

[Consideration of drug absorption in customizing drug therapy].

Walter-Sack I, Haefeli WE. Walter-Sack I, et al. Among authors: haefeli we. Ther Umsch. 2000 Sep;57(9):557-62. doi: 10.1024/0040-5930.57.9.557. Ther Umsch. 2000. PMID: 11036435 Review. German.

7

[Clinically relevant adverse drug interactions].

Martin-Facklam M, Haefeli WE. Martin-Facklam M, et al. Among authors: haefeli we. Ther Umsch. 2000 Sep;57(9):579-83. doi: 10.1024/0040-5930.57.9.579. Ther Umsch. 2000. PMID: 11036439 Review. German.

8

Drug dosage in patients with renal failure optimized by immediate concurrent feedback.

Falconnier AD, Haefeli WE, Schoenenberger RA, Surber C, Martin-Facklam M. Falconnier AD, et al. Among authors: haefeli we. J Gen Intern Med. 2001 Jun;16(6):369-75. doi: 10.1046/j.1525-1497.2001.016006369.x. J Gen Intern Med. 2001. PMID: 11422633 Free PMC article.

9

[Framework for biomedical research involving human subjects - algorithms for planning and organisation].

Walter-Sack I, Haefeli WE. Walter-Sack I, et al. Among authors: haefeli we. Dtsch Med Wochenschr. 2002 Mar 22;127(12):627-33. doi: 10.1055/s-2002-22673. Dtsch Med Wochenschr. 2002. PMID: 11907867 German. No abstract available.

10

Dose-dependent increase of saquinavir bioavailability by the pharmaceutic aid cremophor EL.

Martin-Facklam M, Burhenne J, Ding R, Fricker R, Mikus G, Walter-Sack I, Haefeli WE. Martin-Facklam M, et al. Among authors: haefeli we. Br J Clin Pharmacol. 2002 Jun;53(6):576-81. doi: 10.1046/j.1365-2125.2002.01595.x. Br J Clin Pharmacol. 2002. PMID: 12047481 Free PMC article. Clinical Trial.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

581 results

Search Page